Invitrogen™ Mouse VEGFR3 ELISA Kit

Ref.: BL-RE-106330Manufacturer ref.: EM73RB 96 tests
€722.00 excl. VAT

Mouse VEGFR3 quantitates mouse VEGFR3 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant mouse VEGFR3.

Accession number
AI323512 ; Chy ; ascites chyleux ; FLT4 ; FLT-4 ; FLT41 ; tyrosine kinase 4 lié au fms ; tyrosine kinase 4 semblable au FMS ; tyrosine kinase 4 lié au fms ; LMPH1A ; PCL ; proteins-tyrosine kinases des récepteurs ; VEGFR 3 soluble ; sVEGFR 3 ; récepteur de tyrosine-protein kinase FLT4 ; récepteur de facteur de croissance endothélial vasculaire 3 ; récepteur de facteur de croissance endothélial vasculaire 3 ; VEGF R3 ; Vegfr3 ; VEGFR-3
Dose range
0.2 to 50 ng/ml
Sensitivity of the dosage
0.2 ng/ml
Conjugate
Biotin
Product type
ELISA
Brand
Invitrogen

Mouse VEGFR3 quantitates mouse VEGFR3 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant mouse VEGFR3.

Mouse VEGFR3 quantitates mouse VEGFR3 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant mouse VEGFR3.

Vascular endothelial growth factor is a key regulator of the development of blood vessels in embryos and l-angiogenesis in adult tissues. Unlike VEGF, VEGFC as a combination stimulates the growth of lymphatic vessels through its specific VEGFR-3 lymphatic endothelial receptor. In 1998, Dumont showed that the targeted inactivation of the VEGFR-3 gene in mice resulted in defective development of blood vessels in early embryos. Vasculogenesis and benzogenesis occurred, but large vessels became abnormally organized with defective lumens, resulting in fluid accumulation in the pericardial cavity and cardiovascular failure on embryonic day 9.5. Thus, VEGFR3 plays a key role in the development of the embryonic cardiovascular system before the emergence of lymphatic vessels.

Sensitivity

Sensitivity of dosage: 0.2 ng/ml.

Measurement range

Dose range: 0.2 to 50 ng/ml.

Duration of dosing

Total duration of dosing: 4 h 45 min.

Target

Target: VEGF receiver 3.

Samples

Sample type: Plasma, Serum, Surnatant (plasma volume, 50 µl; supernatant, 50 µl; serum, 50 µl).

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)17194923
Specifications
Accession numberAI323512; Chy ; ascites chylys ; FLT4; FLT-4; FLT41; tyrosine kinase 4 bound to fms; tyrosine kinase 4 similar to FMS; tyrosine kinase 4 bound to fms; LMPH1A; PCL; protein-tyrosine kinase receptors; VEGFR 3 soluble; sVEGFR 3; tyrosine protein kinase receptor FLT4; receptor
Dose range0.2 to 50 ng/ml
Sensitivity of the dosage0.2 ng/ml
ConjugateBiotin
Product typeELISA
Type of samplePlasma, Serum, Surnatant
For use with (equipment)Colorimetric microplate reader
Genetic identification (Enter)P35917
Gene symbol(s)FLT4
Coefficient of inter-dose variation<12%
Coefficient of intra-dose variation<10%
Contents of kits96 pre-coated well plate, standard, dosing diluent concentrate, biotinylated detection antibody, SAV-HRP, washing pad, chromogen, stop solution, adhesive plate lids
Marker or dyeHRP
Quantity96 tests
Regulatory statusUse exclusively for research
TargetVEGF 3 receiver
Test time1 h 20 min
Physical characteristics
Volume of samplePlasma, 50 µl; supernatant, 50 µl; serum, 50 µl
Storage and shipping
Storage conditions2°C to 8°C
Total duration of dosing4 h 45 min

Origin and customs

Manufacturer ref.EM73RB
Country of originUnited States
HS customs code3002 12 00 00
A question or a specific configuration?
Contact us for a quote.